← All trials
NCT03141970
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2015
- Primary completion
- Mar 31, 2020
- Completion date
- Mar 31, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 156
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- All India Institute of Medical SciencesLead sponsor
- University of MichiganOverall official - principal investigator
- All India Institute of Medical SciencesOverall official - principal investigator
- University of MichiganCollaborator
- NephCure Accelerating Cures InstituteCollaborator
- All India Institute of Medical SciencesReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.